Cargando…
Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France
BACKGROUND: Prosthetic joint infections (PJI) are a major cause of morbidity and mortality burden worldwide. While surgical management is well defined, rifampicin (RIF) dose remains controversial. The aim of our study was to determine whether Rifampicin dose impact infection outcomes in PJI due to S...
Autores principales: | Tonnelier, M., Bouras, A., Joseph, C., Samad, Y. El, Brunschweiler, B., Schmit, J.-L., Mabille, C., Lanoix, J-P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881571/ https://www.ncbi.nlm.nih.gov/pubmed/33579208 http://dx.doi.org/10.1186/s12879-021-05832-2 |
Ejemplares similares
-
Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations
por: Fiaux, E., et al.
Publicado: (2016) -
Treatment of prosthetic joint infections due to Propionibacterium: Similar results in 60 patients treated with and without rifampicin
por: Jacobs, Anouk M E, et al.
Publicado: (2016) -
Cutibacterium acnes Prosthetic Joint Infections: Is Rifampicin-Combination Therapy Beneficial?
por: Saltiel, Grégoire, et al.
Publicado: (2022) -
Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures
por: Gutiérrez-González, Raquel, et al.
Publicado: (2010) -
Staphylococcus capitis isolated from prosthetic joint infections
por: Tevell, S., et al.
Publicado: (2016)